Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites

Running, not enrolling · Phase 4

Conditions studied: Smoking Cessation

In brief

This study is to help determine the most effective type or combination of treatments to offer patients seeking lung cancer screening who are smokers to help them reduce the number of cigarettes they smoke, or quit smoking. The investigators long term goal is to increase the benefits of lung cancer screening by providing a blue print of best practices for screening sites to deliver tobacco treatment to their patients who are smokers, in a way that does not add burden to screening site staff and increases the chances of patients quitting smoking.

Key facts

Study ID

NCT03315910

Run by

Memorial Sloan Kettering Cancer Center

People needed

807

Starts

2017-10-10

Expected to finish

2026-10-01

Last updated by the study team

2025-11-24

Who can join

Age: 50 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Site Eligibility (as per SC self-report)
• \& Must be designated as an American College of Radiology (ACR) designated lung cancer screening site
• Reports at least one year of lung cancer screening experience
• Reports conducting at least 20 new initial screenings per month Site Coordinator (SC) Eligibility (as per SC self-report)
• Employed as a full-time Site Coordinator at participating lung cancer screening site Patient Eligibility (as per self-report)
• Between the ages of 50-80 years old
• Seeking baseline or annual follow-up LDCT lung cancer screening
• Have at least a 20 pack-year history of smoking
• Currently a smoker, defined as self-reported cigarette smoking (some days, every day) within the past 30 days.
• Must be reachable by telephone
• Must be English or Spanish speaking due to the study materials being available in only these languages and limited available resources for translation.

You may not qualify if…

• Patient (as per self-report)
• NRT is medically contraindicated (e.g., recent heart attack within the last 2 weeks or, unstable/worsening angina).
• Smokers who are receiving other tobacco treatment services or have used cessation medications (NRT, bupropion, varenicline) within the past month.

Where it is running

• University of Southern California (Data Collection Only) — Los Angeles, California, United States
• John Muir Health — Walnut Creek, California, United States
• WellStar Health System — La Grange, Georgia, United States
• Rush University Medical Center — Chicago, Illinois, United States
• Riverside Healthcare — Kankakee, Illinois, United States
• St. Mary Medical Center, Community Healthcare System — Crown Point, Indiana, United States
• MercyOne Des Moines Medical Center (Data Collection Only) — Des Moines, Iowa, United States
• Maine Medical Center Cancer Institute — Scarborough, Maine, United States
• Henry Ford Hospital (Data collection only) — Detroit, Michigan, United States
• Munson Healthcare — Traverse City, Michigan, United States
• NYU Winthrop Hospital — Mineola, New York, United States
• Memorial Sloan Kettering Cancer Center — New York, New York, United States
• Weill Cornell Medical Center — New York, New York, United States
• Montefiore Medical Center (Data Collection Only) — The Bronx, New York, United States
• Carolinas Healthcare System Blue Ridge — Morganton, North Carolina, United States
• Fairfield Medical Center — Lancaster, Ohio, United States
• Legacy Health — Portland, Oregon, United States
• Temple University — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.